ArcticZymes Technologies Past Earnings Performance
Past criteria checks 2/6
ArcticZymes Technologies's earnings have been declining at an average annual rate of -9%, while the Biotechs industry saw earnings growing at 7.7% annually. Revenues have been growing at an average rate of 10% per year. ArcticZymes Technologies's return on equity is 1.5%, and it has net margins of 4.2%.
Key information
-9.0%
Earnings growth rate
-9.6%
EPS growth rate
Biotechs Industry Growth | 20.9% |
Revenue growth rate | 10.0% |
Return on equity | 1.5% |
Net Margin | 4.2% |
Next Earnings Update | 13 Feb 2025 |
Recent past performance updates
ArcticZymes Technologies' (OB:AZT) Solid Earnings May Rest On Weak Foundations
Aug 30ArcticZymes Technologies' (OB:AZT) Shareholders Have More To Worry About Than Only Soft Earnings
Feb 08Recent updates
Take Care Before Jumping Onto ArcticZymes Technologies ASA (OB:AZT) Even Though It's 25% Cheaper
Nov 28Analysts Are More Bearish On ArcticZymes Technologies ASA (OB:AZT) Than They Used To Be
Nov 12ArcticZymes Technologies ASA Just Missed Earnings With A Surprise Loss - Here Are Analysts Latest Forecasts
Nov 09The Price Is Right For ArcticZymes Technologies ASA (OB:AZT) Even After Diving 28%
Aug 31ArcticZymes Technologies' (OB:AZT) Solid Earnings May Rest On Weak Foundations
Aug 30ArcticZymes Technologies ASA Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Aug 25Earnings Miss: ArcticZymes Technologies ASA Missed EPS By 17% And Analysts Are Revising Their Forecasts
May 12ArcticZymes Technologies' (OB:AZT) Shareholders Have More To Worry About Than Only Soft Earnings
Feb 08ArcticZymes Technologies ASA Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Feb 04Investors Aren't Buying ArcticZymes Technologies ASA's (OB:AZT) Revenues
Feb 02ArcticZymes Technologies ASA's (OB:AZT) Sole Analyst Just Made A Substantial Upgrade To Their Forecasts
Apr 29Downgrade: Here's How This Analyst Sees ArcticZymes Technologies ASA (OB:AZT) Performing In The Near Term
Apr 15One Analyst Just Shaved Their ArcticZymes Technologies ASA (OB:AZT) Forecasts Dramatically
Jan 13Here's What Analysts Are Forecasting For ArcticZymes Technologies ASA (OB:AZT) After Its First-Quarter Results
May 01Revenue & Expenses Breakdown
How ArcticZymes Technologies makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 24 | 111 | 5 | 64 | 0 |
30 Jun 24 | 118 | 15 | 63 | 0 |
31 Mar 24 | 118 | 18 | 63 | 0 |
31 Dec 23 | 120 | 19 | 61 | 0 |
30 Sep 23 | 119 | 20 | 60 | 0 |
30 Jun 23 | 118 | 16 | 64 | 0 |
31 Mar 23 | 120 | 17 | 63 | 0 |
31 Dec 22 | 138 | 33 | 61 | 0 |
30 Sep 22 | 150 | 47 | 59 | 0 |
30 Jun 22 | 147 | 52 | 52 | 0 |
31 Mar 22 | 139 | 48 | 52 | 0 |
31 Dec 21 | 131 | 46 | 48 | 0 |
30 Sep 21 | 114 | 68 | 45 | 0 |
30 Jun 21 | 108 | 67 | 43 | 0 |
31 Mar 21 | 120 | 84 | 37 | 0 |
31 Dec 20 | 98 | 74 | 35 | 0 |
30 Sep 20 | 64 | 43 | 27 | 0 |
30 Jun 20 | 68 | 37 | 29 | 0 |
31 Mar 20 | 88 | 8 | 46 | 0 |
31 Dec 19 | 49 | -1 | 34 | 0 |
30 Sep 19 | 80 | -9 | 49 | 0 |
30 Jun 19 | 79 | -10 | 47 | 0 |
31 Mar 19 | 73 | -13 | 47 | 0 |
31 Dec 18 | 73 | -14 | 46 | 0 |
30 Sep 18 | 70 | -20 | 49 | 0 |
30 Jun 18 | 63 | -27 | 50 | 0 |
31 Mar 18 | 69 | -27 | 51 | 0 |
31 Dec 17 | 73 | -25 | 52 | 0 |
30 Sep 17 | 74 | -26 | 59 | 0 |
30 Jun 17 | 80 | -24 | 58 | 0 |
31 Mar 17 | 79 | -21 | 57 | 0 |
31 Dec 16 | 79 | -20 | 57 | 0 |
30 Sep 16 | 78 | -20 | 53 | 0 |
30 Jun 16 | 72 | -19 | 51 | 0 |
31 Mar 16 | 66 | -18 | 49 | 0 |
31 Dec 15 | 59 | -17 | 47 | 0 |
30 Sep 15 | 55 | -15 | 42 | 0 |
30 Jun 15 | 48 | -16 | 41 | 0 |
31 Mar 15 | 46 | -18 | 39 | 0 |
31 Dec 14 | 38 | -22 | 38 | 0 |
30 Sep 14 | 34 | -23 | 38 | 0 |
30 Jun 14 | 31 | -21 | 37 | 0 |
31 Mar 14 | 26 | -24 | 37 | 0 |
31 Dec 13 | 28 | -23 | 38 | 0 |
Quality Earnings: AZT has high quality earnings.
Growing Profit Margin: AZT's current net profit margins (4.2%) are lower than last year (16.7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: AZT has become profitable over the past 5 years, growing earnings by -9% per year.
Accelerating Growth: AZT's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: AZT had negative earnings growth (-76.7%) over the past year, making it difficult to compare to the Biotechs industry average (-18.2%).
Return on Equity
High ROE: AZT's Return on Equity (1.5%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/19 03:47 |
End of Day Share Price | 2024/12/19 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
ArcticZymes Technologies ASA is covered by 8 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Hans Bohn | Beringer Finance AB |
Mikkel Nyholt-Smedseng | Carnegie Investment Bank AB |
Espen Jørgensen | DNB Markets |